| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 2.16 MB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
This Master's thesis presents a business plan developed as part of a group project, focusing on
the venture development of an innovative approach to reduce postoperative bleeding — a critical
healthcare challenge with substantial health, social, and economic implications. It proposes
preoperative supplementation with microencapsulated arachidonic acid (AA), based on recent
research that correlates higher levels of AA with a reduced risk of bleeding. Within the broader
scope of the group's thesis, this contribution specifically addresses the market opportunity,
competitive landscape, intellectual property strategy, and the framework for people and
partnerships.
Descrição
Palavras-chave
Arachidonic acid Micro encapsulation Vascular surgery Biotechnology Biomedical innovation Venture development Molecular medicine Pharmaceutical sciences Hemostatic agents Pharmacokinetics Intellectual property Market access Business strategy
